Data from ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR EpitopeAndrew C. Phillips, Edward B. Reilly, Peter J. DeVries et al.|Unknown|2023Cited by 0
Figure S1 from Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug ConjugateAndrew C. Phillips, Edward B. Reilly, Erwin R. Boghaert et al.|Unknown|2023Cited by 0
Data from Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug ConjugateAndrew C. Phillips, Edward B. Reilly, Erwin R. Boghaert et al.|Unknown|2023Cited by 0
Supplementary Table 1, Table 2; Supplementary Figure 1 from ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR EpitopeAndrew C. Phillips, Edward B. Reilly, Erwin R. Boghaert et al.|Unknown|2023Cited by 0
Figure S1 from Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug ConjugateAndrew C. Phillips, Edward B. Reilly, Erwin R. Boghaert et al.|Unknown|2023Cited by 0